Novavax shares rise after Covid-19 vaccines launched in UK


the stock rose on Tuesday after the company announced that the first million doses of its Covid-19 vaccine are now available for use in the UK

Shares of


(ticker: NVAX) has struggled this year, falling 86% so far in 2022 and 90% in the past 12 months. The company lowered its full-year revenue guidance back in August and posted a disappointing second quarter due to poor demand for its Covid-19 vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *